These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751 [TBL] [Abstract][Full Text] [Related]
4. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. Turner MS; Kane LP; Morel PA J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514 [TBL] [Abstract][Full Text] [Related]
5. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. Liu H; Bakthavatsalam R; Meng Z; Li Z; Li W; Perkins JD; Reyes J Transplant Proc; 2013 Jun; 45(5):1853-5. PubMed ID: 23769057 [TBL] [Abstract][Full Text] [Related]
6. Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects. Klein O; Ebert LM; Zanker D; Woods K; Tan BS; Fucikova J; Behren A; Davis ID; Maraskovsky E; Chen W; Cebon J Eur J Immunol; 2013 Feb; 43(2):533-9. PubMed ID: 23124877 [TBL] [Abstract][Full Text] [Related]
7. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin. Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839 [TBL] [Abstract][Full Text] [Related]
8. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats. Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro. Singh AK; Horvath KA; Mohiuddin MM Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569 [TBL] [Abstract][Full Text] [Related]
11. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation. Pothoven KL; Kheradmand T; Yang Q; Houlihan JL; Zhang H; Degutes M; Miller SD; Luo X Am J Transplant; 2010 Aug; 10(8):1774-84. PubMed ID: 20626386 [TBL] [Abstract][Full Text] [Related]
13. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related]
14. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569 [TBL] [Abstract][Full Text] [Related]
15. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. Moseman EA; Liang X; Dawson AJ; Panoskaltsis-Mortari A; Krieg AM; Liu YJ; Blazar BR; Chen W J Immunol; 2004 Oct; 173(7):4433-42. PubMed ID: 15383574 [TBL] [Abstract][Full Text] [Related]
16. Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. Tokita D; Sumpter TL; Raimondi G; Zahorchak AF; Wang Z; Nakao A; Mazariegos GV; Abe M; Thomson AW J Hepatol; 2008 Dec; 49(6):1008-18. PubMed ID: 18926588 [TBL] [Abstract][Full Text] [Related]
17. Oscillatory mTOR inhibition and Treg increase in kidney transplantation. Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells. Wang X; Wang W; Xu J; Hong J; Le Q Exp Clin Transplant; 2013 Feb; 11(1):56-62. PubMed ID: 22769982 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions. Boor PP; Metselaar HJ; Mancham S; van der Laan LJ; Kwekkeboom J Clin Exp Immunol; 2013 Dec; 174(3):389-401. PubMed ID: 23968562 [TBL] [Abstract][Full Text] [Related]
20. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]